BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:24 pm Sale | 2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 3,944,194 7.800% | -717,000 (-15.38%) | Filing |
| 2024-11-14 4:34 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 4,661,194 8.800% | 1,921,599 (+70.14%) | Filing |
| 2024-02-14 09:24 am Purchase | 2023-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,739,595 6.400% | 267,268 (+10.81%) | Filing |
| 2022-03-24 4:22 pm Purchase | 2022-03-14 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% | 2,472,327 (New Position) | Filing |